New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
NTI Endorses Biosecurity Modernization and Innovation Act of 2026
Read Full Article on Nuclear Threat Initiative →
This article was originally published on Nuclear Threat Initiative.